Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck
- PMID: 4429642
- DOI: 10.1016/0002-9610(74)90268-2
Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck
Similar articles
-
Immunologic abnormalities in head and neck cancer.Am J Surg. 1974 Oct;128(4):534-8. doi: 10.1016/0002-9610(74)90269-4. Am J Surg. 1974. PMID: 4422512 No abstract available.
-
Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens. Prognostic significance in patients with lung cancer.J Thorac Cardiovasc Surg. 1973 Oct;66(4):557-62. J Thorac Cardiovasc Surg. 1973. PMID: 4755446 No abstract available.
-
Reduced in vivo cell-mediated immune responses to mumps, tuberculin, and streptokinase/streptodornase but not to Candida albicans in oral lichen planus.J Dent Res. 1999 Nov;78(11):1704-10. doi: 10.1177/00220345990780110701. J Dent Res. 1999. PMID: 10576166
-
Responses of neoplasms to local immunotherapy.Am J Clin Pathol. 1974 Aug;62(2):281-9. doi: 10.1093/ajcp/62.2.281. Am J Clin Pathol. 1974. PMID: 4602090 Review. No abstract available.
-
Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.Semin Oncol. 1977 Dec;4(4):431-9. Semin Oncol. 1977. PMID: 339354 Review. No abstract available.
Cited by
-
Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma.Clin Cancer Res. 2015 Jan 1;21(1):30-8. doi: 10.1158/1078-0432.CCR-14-1716. Clin Cancer Res. 2015. PMID: 25564570 Free PMC article. Clinical Trial.
-
Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers.Cancer Immun. 2008 Dec 4;8:16. Cancer Immun. 2008. PMID: 19053167 Free PMC article. Review.
-
Nutritional status and general immune competence in patients with head and neck cancer.J R Soc Med. 1981 Feb;74(2):132-9. doi: 10.1177/014107688107400209. J R Soc Med. 1981. PMID: 7205848 Free PMC article.
-
Observations on immunologic parameters in laryngeal cancer patients.Arch Otorhinolaryngol. 1983;238(3):241-50. doi: 10.1007/BF00453935. Arch Otorhinolaryngol. 1983. PMID: 6606415
-
Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically.Br J Cancer. 1994 Mar;69(3):572-6. doi: 10.1038/bjc.1994.104. Br J Cancer. 1994. PMID: 8123489 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources